Author

Keith S. Bahjat

Observed names: Bahjat, Keith, K S Bahjat, K. Bahjat, K. S. Bahjat, KS Bahjat, Keith Bahjat, Keith S Bahjat

Observed institutions: La Jolla Institute for Immunology, Beth Israel Deaconess Medical Center, Mayo Clinic, Harvard University, Oregon Health & Science University, University of Florida Health, Providence Portland Medical Center, University of Florida, Bristol-Myers Squibb (United States), Oregon Clinic, Dana-Farber Cancer Institute, Cerus (United States), University of California, Berkeley

OpenAlex ID: A5001477657

Designer vaccine nanodiscs for personalized cancer immunotherapy

2016 · Rui Kuai, Lukasz J. Ochyl, et al. · Nature Materials · 1,057

VISTA is an acidic pH-selective ligand for PSGL-1

2019 · Robert J. Johnston, Linhui Julie Su, et al. · Nature · 404

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

2016 · Kristina H. Young, Jason R. Baird, et al. · PLoS ONE · 325

PDF

Listeria -based cancer vaccines that segregate immunogenicity from toxicity

2004 · Dirk G. Brockstedt, Martin A. Giedlin, et al. · Proceedings of the National Academy of Sciences · 300

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

2001 · Yuri N. Naumov, Keith S. Bahjat, et al. · Proceedings of the National Academy of Sciences · 293

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

2015 · Jason R. Baird, David Friedman, et al. · Cancer Research · 258

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

2008 · Nathan W. Schmidt, Rebecca L. Podyminogin, et al. · Proceedings of the National Academy of Sciences · 238

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

2015 · Dalil Hannani, Marie Vétizou, et al. · Cell Research · 162

PDF

CD8+ T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells

2010 · Alice W. Yewdall, Scott B. Drutman, et al. · PLoS ONE · 152

PDF

NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses

2009 · Philippe Krebs, Michael J. Barnes, et al. · Blood · 152

PDF

Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity

2005 · D G Brockstedt, K S Bahjat, et al. · Nature Medicine · 136

Erratum: Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25

2015 · Dalil Hannani, Marie Vétizou, et al. · Cell Research · 133

Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells

2020 · Chen Zhu, Zhili Song, et al. · Frontiers in Immunology · 116

PDF

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

2016 · Todd Crocenzi, Benjamin Cottam, et al. · Journal for ImmunoTherapy of Cancer · 109

PDF

Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway

2006 · Edith Janssen, Koichi Tabeta, et al. · Immunity · 92

PDF

Autoregulation of Human Monocyte-Derived Dendritic Cell Maturation and IL-12 Production by Cyclooxygenase- 2-Mediated Prostanoid Production

2000 · Donna S Whittaker, Keith S Bahjat, et al. · The Journal of Immunology · 67

Cytosolic Entry Controls CD8+-T-Cell Potency during Bacterial Infection

2006 · Keith S. Bahjat, Weiqun Liu, et al. · Infection and Immunity · 62

Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade

2020 · Rita Greco, Hongjing Qu, et al. · OncoImmunology · 58

PDF

Constitutive Activation of the PrfA Regulon Enhances the Potency of Vaccines Based on Live-Attenuated and Killed but Metabolically Active Listeria monocytogenes Strains

2008 · Peter Lauer, Bill Hanson, et al. · Infection and Immunity · 58

Selective Targeting of Antitumor Immune Responses with Engineered Live-Attenuated Listeria monocytogenes

2006 · Kiyoshi Yoshimura, Ajay Jain, et al. · Cancer Research · 55

Increased Survival in Sepsis by In Vivo Adenovirus-Induced Expression of IL-10 in Dendritic Cells

2002 · Andreas Oberholzer, Caroline Oberholzer, et al. · The Journal of Immunology · 54

Impact of Preexisting Vector-Specific Immunity on Vaccine Potency: Characterization ofListeria monocytogenes-Specific Humoral and Cellular Immunity in Humans and Modeling Studies Using Recombinant Vaccines in Mice

2009 · Meredith L. Leong, Johannes Hampl, et al. · Infection and Immunity · 53

Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab

2015 · Yoshinobu Koguchi, Helena M. Hoen, et al. · Cancer Research · 51

The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor

2013 · Marka R. Crittenden, Talicia Savage, et al. · PLoS ONE · 43

PDF

Increased Expression of the Lymphocyte Early Activation Marker Cd69 in Peripheral Blood Correlates With Histologic Evidence of Cardiac Allograft Rejection1

2000 · Kenneth O. Schowengerdt, F. Jay Fricker, et al. · Transplantation · 42

Works count: 95

Citation count: 4,820

H-index: 28

I10-index: 39